Quick Takeaways
- J. WOOD CAPITAL ADVISORS LLC filed SCHEDULE 13G for Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN).
- Disclosed ownership: 5.4%.
- Date of event: 25 Mar 2025.
J. WOOD CAPITAL ADVISORS LLC - 25 Mar 2025 SCHEDULE 13G Report for Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN)
- Filing Manager
- J. WOOD CAPITAL ADVISORS LLC
- Reporting Manager
- J. Wood Capital Advisors LLC
- Symbol
- CYCN
- Shares outstanding
- 3,367,000 shares
- Disclosed Ownership
- 181,818 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Oct 2025, 16:05:17 UTC
- Date of event
- 25 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"J. WOOD CAPITAL ADVISORS LLC disclosed 5.4% ownership in Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN) on 25 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Oct 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| J. Wood Capital Advisors LLC | 5.4% | 181,818 | 0 | 181,818 | /s/ Jason Wood | Jason Wood, Chief Executive Officer | |
| Jason Wood | 5.4% | 181,818 | 0 | 181,818 | /s/ Jason Wood | Jason Wood |